GSK Re-enters Oncology Arena with US$5.1 B Tesaro Acquisition
By Michelle Liu
Pharma Deals Review: Vol 2018 Issue 12 (Table of Contents)
Published: 7 Dec-2018
DOI: 10.3833/pdr.v2018.i12.2379 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Jumping back into the cancer field, GlaxoSmithKline (GSK) has agreed to acquire oncology specialist Tesaro in a deal worth £4 B (US$5...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS